Tyrosine Kinase Inhibitors in Glioblastoma: Refining Precision Medicine

In this online program experts discuss recent advances in the use of tyrosine kinase inhibitors to optimize outcomes in patients with glioblastoma. Watch the on-demand Webcast and download the slides from a dynamic CCO symposium to learn more about how to optimize this approach in your clinical practice.

Share

Program Content

Activities

TKIs in GBM
Tyrosine Kinase Inhibitors in Glioblastoma: Refining Precision Medicine
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2020

Expires: January 15, 2021

Activities

NTRK in GBM
Targeting NTRK Gene Fusions in GBM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2019

Expires: November 20, 2020

Multiple Receptor TKIs in GBM
Multiple Receptor TKIs in Recurrent GBM in the Absence of Actionable Targets
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2019

Expires: November 20, 2020

Clinical Trials in GBM
Current Clinical Trials and Unique Small Molecule Targets in GBM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2019

Expires: November 20, 2020

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma